Standard Chem & Pharm
生達化學製藥股份有限公司
Standard Chem & Pharm is a Taiwan TWSE-listed biotechnology company; its most advanced asset is Amlobin-O (Commercialized, Cardiovascular disease and blood pressure control), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| Amlobin-O | — | Commercialized | Cardiovascular disease and blood pressure control | Taiwan | 2026-04-20 | Company disclosure |
| Bistin Tab. | — | Commercialized | Allergic symptoms | Taiwan | 2026-04-20 | Company disclosure |
| Febuton | — | Commercialized | Hyperuricemia | Taiwan | 2026-04-20 | Company disclosure |
Key events
No verified events in the past twelve months.